Institutions are buying quietly.
$Vir Biotechnology (VIR.US)$ Only fools would sell. I added it to the risk control limit, it's a pity. The company's pipeline alone is worth 30-50. The existing order is worth 5 yuan. GSK can easily add another 5 yuan with any deal.
The current approach is to discuss the acquisition. Estimated acquisition at 70?
GSK took 20K in Canada. Multiply by 2100. 41M, sigh...
The current approach is to discuss the acquisition. Estimated acquisition at 70?
GSK took 20K in Canada. Multiply by 2100. 41M, sigh...
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
CFA, FRM, P-Quant。然而自己投资并不量化…个人投资观点，不代表供职的银行或客户（反正我看不到）。不提供投资建议。
247Followers
20Following
1831Visitors
Follow
QMengColdJoke OP : It's obvious that big orders are coming in. Whoever wants to sell will sell it, insider, ETF. I'm afraid to go back to 60. You can still have 45
blue4u QMengColdJoke OP : It's going up
QMengColdJoke OP blue4u : Yeah... yesterday's news went up today. Ah, I clearly bet on the treasure, and the cost is actually the same as chasing in Reddit netizens today![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")